OLIGODENDROGLIAL COMPONENT PRESENT

Clinical trials for OLIGODENDROGLIAL COMPONENT PRESENT explained in plain language.

Never miss a new study

Get alerted when new OLIGODENDROGLIAL COMPONENT PRESENT trials appear

Sign up with your email to follow new studies for OLIGODENDROGLIAL COMPONENT PRESENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New brain cancer fight: adding Whole-Brain radiation to stop tumor return

Disease control Completed

This study tested whether adding whole-brain radiation therapy and a drug called plerixafor to the standard treatment could better control an aggressive type of brain tumor called glioblastoma (GBM). It involved 21 adults who had recently been diagnosed and had surgery. The main …

Matched conditions: OLIGODENDROGLIAL COMPONENT PRESENT

Phase: PHASE2 • Sponsor: Lawrence D Recht • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

OLIGODENDROGLIAL COMPONENT PRESENT

Get alerted when new OLIGODENDROGLIAL COMPONENT PRESENT trials appear

New brain cancer fight: adding Whole-Brain radiation to stop tumor return